NPPA and Cognitive impairment: Plasma KP metabolites were quantified by LC-MS/MS, inflammatory markers by high-sensitivity ELISA, and immune-cell subsets by flow cytometry.<h4>Results</h4>FES showed marked baseline cognitive impairment with stepwise improvement by week 6 and month 6.